In insulin-resistant states, such as type 2 diabetes and NAFLD, hepatic overproduction of SeP exacerbates metabolic dysfunction by inhibiting insulin action in peripheral tissues (24, 73). The gene discussed is INS; the disease is type 2 diabetes mellitus.